|

Placebo sublingual tablet Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Tonix Pharmaceuticals, Inc.1

Indications

  • Major Depressive Episode (MDE)1
  • Major Depressive Disorder (MDD)1
  • Depression1

Phoenix, Arizona1 trial

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

IMA Clinical Research- Phoenix

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.